A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: NP001
DRUG: NP001
DRUG: Placebo

Sponsor

Neuraltus Pharmaceuticals, Inc.